Endocrinology News and Research

Latest Endocrinology News and Research

Higher prevalence of anxiety disorders in youth with chronic medical conditions

Youth who report one of the seven chronic medical conditions (CMCs), including asthma, congenital heart disease, diabetes, epilepsy, inflammatory bowel disease, juvenile idiopathic arthritis, and sickle cell disease, are often diagnosed with an anxiety disorder.

4 May 2020

Scientists call for labeling to warn public about arsenic levels in rice

Scientists have called for labeling to warn the public about levels of arsenic in rice, after their research found half of rice varieties studied exceeded maximum limits on the deadly toxin.

4 May 2020

Scientists identify two genes that regulate healthy fat levels in mice

Salk and Scripps Research Institute scientists, along with collaborators at the pharmaceutical company Lundbeck, identified two genes that can regulate levels of healthy fats, called FAHFAs, in mice.

4 May 2020

Impact of COVID-19 on pregnancy and breastfed infants

Pregnant women are among those at high risk of developing COVID-19, as confirmed in Wuhan early in the pandemic. A new study from Portugal published on the preprint server medRxiv in May 2020 analyses the data on the impact of COVID-19 on pregnancy and disease outcomes, using published cases of pregnant women diagnosed with the illness.

4 May 2020

Study: Unique glucose-sensing neurons in the brain prevent severe hypoglycemia

Low blood sugar levels, known as hypoglycemia, can be a life-threatening situation, especially for people with type 1 diabetes who rely on intensive insulin therapy to prevent blood sugar from going too high.

4 May 2020

Blood sugar control is key for people with type 2 diabetes and COVID-19

A study reported in the journal Cell Metabolism on April 30 adds to the evidence that people with type 2 diabetes (T2D) are at greater risk of a poor outcome should they become infected with the virus that causes COVID-19.

4 May 2020

Hydroxychloroquine combined with azithromycin and abnormal heart rhythms in COVID-19 patients

A new study shows that the initially lauded combination of drugs against COVID-19 - Hydroxychloroquine and Chloroquine combined with azithromycin, could lead to abnormal and life-threatening heart rhythms. In patients hospitalized with the novel coronavirus infection or SARS CoV-2, this combination can lead to prolonged QT interval as can be detected on ECG.

3 May 2020

Anti-malarial drug use for COVID-19 associated with increased risk of cardiac arrhythmias

Since the World Health Organization declared COVID-19 a Public Health Concern of Global Interest on January 30, more than one million have tested positive for the illness in the United States, and more than 62,000 have died.

3 May 2020

AHA awards grants to 12 teams for fast-tracked heart and brain health research related to COVID-19

Less than a month after issuing a rapid response call for scientific research proposals for fast-tracked studies of the effects of COVID-19 on the body's cardiovascular and cerebrovascular systems, the American Heart Association has awarded $1.2 million in grants to teams at 12 institutions across the U.S. to begin this unprecedented work.

2 May 2020

Identifying high-risk groups for COVID-19 in India

A new study from the Center for Disease Dynamics, Economics and Policy sets out indicators that identify the populations at the highest risk for COVID-19 in India. The study appears on the preprint website medRxiv in April 2020.

30 Apr 2020

New clinical trial to assess whether hypertension drug may reduce COVID-19 severity

Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic kidney disease might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

30 Apr 2020

Racial inequalities in liver cancer mortality increased after introduction of hepatitis C drugs

In the United States, hepatocellular or liver cancer deaths have doubled since 1979. Hepatitis C virus is the leading cause of liver cancer.

30 Apr 2020

COVID-19 pandemic will bring additional cancer deaths

With over 3.25 million people infected, healthcare systems of even the most developed nations are overwhelmed. Cancer patients and survivors, for example, are particularly vulnerable during this epidemic and not only because of their increased vulnerable immunocompromised state, which makes them prone to the infection. They are also at risk of missing out on essential cancer care due to the unavailability of resources.

30 Apr 2020